IQVIA Technologies is stepping up to the challenge of clinical trial tech proliferation that’s impacting the entire industry. See how you can be part of the solution by joining IQVIA One Home for Sites.
You need to spend more time with patients and less time with systems. IQVIA Technologies is stepping up to solve your challenges with One Home for Sites.
IDC sees IQVIA One Home for Sites as well positioned to transform the site experience, driving faster and improved patient outcomes.
Read IDC’s analysis of the launch of One Home for Sites and its potential to address the multisystem access fatigue that impacts sites’ ability to take on clinical trials.
Since 2010, global R&D spending on CRO and tech vendor services has nearly doubled. But instead of seeing faster trials, the industry measured longer study timelines.
Investigators and their staff are telling us that next-gen tools and third-party vendors now add too much complexity to their lives. The result: they’re turning down trials.
in spending for clinical technology and services from 2010-2020
in Phase 3 study initiation times since 2015
report insufficient bandwidth to run trials
Many sponsors, CROs, and tech vendors have individual initiatives to improve the site experience across their own trials and products. But investigators run trials for multiple sponsors, and sponsors use products from many different vendors.
Unless these individual efforts get connected at the site level, they won’t reduce complexity or deliver a positive impact on the industry.
One Home for Sites is the only product that serves as a neutral connector of the key systems and tasks a site needs to perform across all the clinical trials it is conducting.
 |
Single sign-on |
 |
Study organization |
 |
Site engagement & communication |
For nearly 60 years, IQVIA has been developing successful products built on industry collaborations that move healthcare forward.
With a history of site-focused products from our DrugDev heritage, IQVIA is the ONLY provider with everything needed to start this movement:
Join us as we bring together sites, sponsors, and tech partners to build One Home for Sites.
Access this IDC Research Note covering IQVIA One Home for Sites and its potential to address the multisystem-access fatigue that sites are experiencing.
Explore IDC’s point of view that the One Home product launch underscores IQVIA's leadership in unifying the industry to transform clinical trials.
Be a part of the only platform that’s bringing the industry together to help sites survive and thrive, along with their patients.
Be a part of the only platform that’s bringing the industry together to help sites survive and thrive, along with their patients.
You need to spend more time with patients and less time with systems. IQVIA Technologies is stepping up to solve your challenges with One Home for Sites.
Communication, collaboration and transparency between sites and sponsors mean trials start up and close out faster.
Increase transparency, improve communications and reduce administrative burden for all clinical trial stakeholders.
.svg){kind=icon}
